QXAS yields 25.02% · MRK yields 2.76%● Live data
📍 QXAS pulled ahead of the other in Year 1
Combined, QXAS + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QXAS + MRK for your $10,000?
QXAS seeks 2x daily exposure to the largest crypto assets, excluding Bitcoin (BTC), stablecoins, and memecoins. It does not hold crypto directly, but gains exposure via swaps, options, futures contracts, or ETPs, targeting up to 10 crypto assets traded in US exchanges. The fund uses options contracts for leveraged exposure, allowing dynamic adjustments based on market conditions, liquidity, or pricing. The fund buys standardized, cash-settled futures to manage contango and backwardation and invests in ETPs for long exposure. The fund holds cash and cash-like instruments as collateral and may enter reverse repurchase agreements. Up to 25% of assets may be invested through a wholly owned Cayman Islands subsidiary. The market cap-weighted portfolio is reviewed and rebalanced at least monthly, capping each asset at 50%. The actively managed fund has full discretion to adjust at any time. Daily leverage resets may cause long-term returns to differ from the underlying assets.
Full QXAS Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.